Thromboembolicdiseaseshavebecomeaglobalpublichealthchallenge,withover50millionnewcardiovascularcasesannually.Asacoreanticoagulantdrug,HeparinSodiumiswidelyusedinhemodialysis,deepveinthrombosispreventi
Thromboembolicdiseases,includingdeepveinthrombosisandpulmonaryembolism,havebecomeaglobalpublichealthburden,affectingmillionsofpatientsannually.Asagold-standardlowmolecularweightheparin,EnoxaparinSodiu
TheglobalpharmaceuticalmarkethaswitnessedsignificantvolatilityinHeparinSodiumpricesince2024,withanotablereboundof27%inthefirstquarterof2025alone,followingaperiodofbottomingout.Forpharmaceuticaldistrib
Anticoagulanttherapyrequiresprecisebalancingofefficacyandsafety,especiallyforspecialpopulationssuchaspregnantwomen,elderlypatientsundergoingorthopedicsurgery,andbreastfeedingmothers.Thesegroupsfaceuni
Theglobalheparinmarketisundergoingacriticaltransformation,drivenbysupplychainreconfiguration,risingdemandfromagingpopulations,andbreakthroughsinbioengineeringtechnologies.Ashealthcareprovidersandpharm